Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghiorzo

Showing results (31-40 of 147) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
INK4/ARF germline alterations in pancreatic cancer patientsP Ghiorzo, L Pastorino, L Bonelli, et al.
Cancers|June 2, 2021
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic VariantsFrancesco Spagnolo, Bruna Dalmasso, Enrica Tanda, et al.
Pigment Cell & Melanoma Research|November 22, 2012
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer historyP Ghiorzo, L Pastorino, P Queirolo, et al.
International Journal of Molecular Sciences|May 14, 2022
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer PatientsBruna Dalmasso, Alberto Puccini, Fabio Catalano, et al.
Journal of the American Academy of Dermatology|October 3, 2018
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patientsBruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, et al.
Pediatric Blood & Cancer|June 16, 2009
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastomaChiara Perfumo, Stefano Parodi, Katia Mazzocco, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 22, 2016
The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian PatientsChristine G Stoehr, Bernhard Walter, Stefan Denzinger, et al.
Journal of Clinical Medicine|February 13, 2025
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 PatientsAndrea Carugno, Giovanni Paolino, Mario Valenti, et al.
Experimental Dermatology|July 19, 2012
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patientsPaola Ghiorzo, Luigina Bonelli, Lorenza Pastorino, et al.
Human Molecular Genetics|January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanomaAlessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.
Pageof 15

Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
INK4/ARF germline alterations in pancreatic cancer patientsP Ghiorzo, L Pastorino, L Bonelli, et al.
Cancers|June 2, 2021
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic VariantsFrancesco Spagnolo, Bruna Dalmasso, Enrica Tanda, et al.
Pigment Cell & Melanoma Research|November 22, 2012
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer historyP Ghiorzo, L Pastorino, P Queirolo, et al.
International Journal of Molecular Sciences|May 14, 2022
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer PatientsBruna Dalmasso, Alberto Puccini, Fabio Catalano, et al.
Journal of the American Academy of Dermatology|October 3, 2018
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patientsBruna Dalmasso, Lorenza Pastorino, Giulia Ciccarese, et al.
Pediatric Blood & Cancer|June 16, 2009
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastomaChiara Perfumo, Stefano Parodi, Katia Mazzocco, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 22, 2016
The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian PatientsChristine G Stoehr, Bernhard Walter, Stefan Denzinger, et al.
Journal of Clinical Medicine|February 13, 2025
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 PatientsAndrea Carugno, Giovanni Paolino, Mario Valenti, et al.
Experimental Dermatology|July 19, 2012
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patientsPaola Ghiorzo, Luigina Bonelli, Lorenza Pastorino, et al.
Human Molecular Genetics|January 23, 2010
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanomaAlessandra Bisio, Sabina Nasti, Jennifer J Jordan, et al.
Pageof 15